Multi-electrode mapping of complex macroreentry atrial tachycardia

Abstract

BackgroundMulti-electrode mapping (MEM) is increasingly applied in ablation of complex atrial arrhythmias. This study aimed to evaluate MEM for analysis and treatment of complex macroreentry atrial tachycardia (MAT). MethodsPatients with MAT related to scarring, history of heart surgery or atrial linear ablation were studied. Patients were mapped with conventional activation mapping (CAM) or MEM. After characterizing the mechanism of atrial tachycardia (AT), the ablation was performed. ResultsThe study consisted of 114 eligible patients, 74 in the CAM and 40 in MEM. Compared with CAM, MEM had a shorter procedure duration (156.7 ± 59.1 ms vs. 127.3 ± 59.3 ms, P = 0.003) and mapping duration (62.6 ± 35.7 ms vs. 30.5 ± 15.3 ms, P < 0.001) and more mapping points (1364.9 ± 828.7 points vs. 148.3 ± 79.6 points, P < 0.001). There were no significant differences between CAM and MEM in acute ablation success rate, complication, postoperative AADs, and ablation duration. The mean disease-free survival time in CAM versus MEM was 20.8 (95% CI: 17.6–24.1) months versus 26.6 (95% CI: 22.7–30.4) months. The median disease-free survival time in the CAM versus MEM was 20.0 (95% CI: 13.9–26.1) months versus 30.0 (95% CI: 26.7–36.3) months. The AT recurrence risk of MEM was 0.522 times that of CAM (HR 95% CI: 0.282–0.968; P = 0.039). ConclusionMEM is strongly recommended in ablation of complex MAT.